Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 21 (sup119) , 230-237
- https://doi.org/10.3109/00365528609087459
Abstract
(1986). Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995. Scandinavian Journal of Gastroenterology: Vol. 21, No. sup119, pp. 230-237. doi: 10.3109/00365528609087459Keywords
This publication has 33 references indexed in Scilit:
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.Gut, 1985
- New somatostatin molecule for management of endocrine tumours.Gut, 1985
- REGRESSION OF METASTATIC VIPOMA WITH SOMATOSTATIN ANALOGUE SMS 201-995The Lancet, 1985
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraNew England Journal of Medicine, 1985
- SomatostatinNew England Journal of Medicine, 1983
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Somatostatin - A Regulatory Modulator Connecting Nutrient Entry and MetabolismHormone and Metabolic Research, 1980
- RAPID IMPROVEMENT OF SKIN LESIONS IN GLUCAGONOMAS WITH INTRAVENOUS SOMATOSTATIN INFUSIONThe Lancet, 1980
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974